K08670658
Kromasil® C18 HPLC Column
5 μm particle size, pore size 100 Å, L × I.D. 125 mm × 4 mm
Sinónimos:
Kromasil C18
About This Item
Productos recomendados
agency
suitable for USP L1
product line
Kromasil®
manufacturer/tradename
Kromasil® KR100-5-C18-4.0X125
availability
available only in USA, Canada and Puerto Rico
technique(s)
HPLC: suitable
L × I.D.
125 mm × 4 mm
matrix active group
C18 (octadecyl) phase
particle size
5 μm
pore size
100 Å
application(s)
food and beverages
separation technique
reversed phase
¿Está buscando productos similares? Visita Guía de comparación de productos
Categorías relacionadas
Application
- QbD-Engineered Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Rutin and Ciprofloxacin HCl in Bilosomal Nanoformulation.: This study leverages the Kromasil® C18 HPLC Column to develop a robust, quality-by-design (QbD) engineered method for simultaneous estimation of rutin and ciprofloxacin, enhancing analytical accuracy in pharmaceutical formulations (Shamim et al., 2023).
- Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide.: Highlights the use of the Kromasil® C18 HPLC Column in implementing green analytical chemistry principles for the analysis of zonisamide, contributing to sustainable laboratory practices (Elsheikh et al., 2023).
- Simple high-performance liquid chromatography-ultraviolet method for simultaneous separation and detection of 14 bisphenol pollutants in building materials.: Demonstrates the efficacy of the Kromasil® C18 HPLC Column in environmental analysis, particularly for the detection of bisphenol pollutants in construction materials, addressing significant environmental health concerns (Han et al., 2023).
- Development and Validation for Quantification of 7-Nitroso Impurity in Sitagliptin by Ultraperformance Liquid Chromatography with Triple Quadrupole Mass Spectrometry.: This paper uses the Kromasil® C18 HPLC Column for the sensitive detection and quantification of impurities in pharmaceutical products, ensuring drug safety and compliance with regulatory standards (Chittireddy et al., 2022).
- Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.: Utilizes the Kromasil®C18 HPLC Column to establish a simple and sensitive method for the analysis of Remogliflozin, aiding in the quality control and development of diabetes medication (Itigimatha et al., 2022).
Legal Information
Elija entre una de las versiones más recientes:
Certificados de análisis (COA)
Lo sentimos, en este momento no disponemos de COAs para este producto en línea.
Si necesita más asistencia, póngase en contacto con Atención al cliente
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico